Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition

Journal of Pathology

Volumn 224, Issue 1, 2011, Pages 78-89

  Yuen, Hiu Fung ^a   Chan, Yuen Kwong ^b   Grills, Claire ^a   McCrudden, Cian M ^a   Gunasekharan, Vignesh ^a   Shi, Zhanzhong ^a,c   Wong, Ashley San Yu ^b   Lappin, Terence R ^a   Chan, Kwok Wah ^b   Fennell, Dean A ^a   Khoo, Ui Soon ^b   Johnston, Patrick G ^a   El Tanani, Mohamed ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

breast cancer; epithelial mesenchymal transition; Pea3; Snail

Indexed keywords

TRANSCRIPTION FACTOR PEA3; TRANSCRIPTION FACTOR SNAIL; TUMOR PROMOTER;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL INVASION; CELL MOTILITY; CHINESE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; METASTASIS; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRANSACTIVATION;

ADENOVIRUS E1A PROTEINS; BREAST NEOPLASMS; CELL NUCLEUS; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 79953767723     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2859     Document Type: Article

References (46)

1. Jemal A, Siegel R, Ward E, et al., Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Suva LJ, Griffin RJ, Makhoul I,. Mechanisms of bone metastases of breast cancer. Endocr Relat Cancer 2009; 16: 703-713.
3. Thiery JP, Acloque H, Huang RY, et al., Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
4. Kalluri R, Weinberg RA,. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
5. Yang J, Weinberg RA,. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14: 818-829. (Pubitemid 351757205)
6. Nieto MA,. The snail superfamily of zinc-finger transcription factors. Nature Rev Mol Cell Biol 2002; 3: 155-166.
7. Yang J, Mani SA, Weinberg RA,. Exploring a new twist on tumor metastasis. Cancer Res 2006; 66: 4549-4552.
8. Yang J, Mani SA, Donaher JL, et al., Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-939. (Pubitemid 38798858)
9. Yuen HF, Chua CW, Chan YP, et al., Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer. Histopathology 2007; 50: 648-658.
10. Hajra KM, Chen DY, Fearon ER,. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62: 1613-1618. (Pubitemid 34408479)
11. Moody SE, Perez D, Pan TC, et al., The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005; 8: 197-209. (Pubitemid 41317591)
12. de Launoit Y, Baert JL, Chotteau A, et al., Structure-function relationships of the PEA3 group of Ets-related transcription factors. Biochem Mol Med 1997; 61: 127-135. (Pubitemid 27347215)
13. Hiroumi H, Dosaka-Akita H, Yoshida K, et al., Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion. Int J Cancer 2001; 93: 786-791. (Pubitemid 32761692)
14. Horiuchi S, Yamamoto H, Min Y, et al., Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. J Pathol 2003; 200: 568-576. (Pubitemid 36987305)
15. Yamamoto H, Horiuchi S, Adachi Y, et al., Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer. Carcinogenesis 2004; 25: 325-332. (Pubitemid 38344398)
16. Sloan KA, Marquez HA, Li J, et al., Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines. Carcinogenesis 2009; 30: 1433-1442.
17. Chen JH, Vercamer C, Li Z, et al., PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene 1996; 13: 1667-1675. (Pubitemid 26377498)
18. Upadhyay S, Liu C, Chatterjee A, et al., LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer. Cancer Res 2006; 66: 7870-7879. (Pubitemid 44299149)
19. Cowden Dahl KD, Dahl R, Kruichak JN, et al., The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia 2009; 11: 1208-1215.
20. Qin L, Liu Z, Chen H, et al., The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Res 2009; 69: 3819-3827.
21. Peinado H, Olmeda D, Cano A,. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature Rev Cancer 2007; 7: 415-428. (Pubitemid 46809165)
22. Barrallo-Gimeno A, Nieto MA,. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005; 132: 3151-3161. (Pubitemid 41167144)
23. Olmeda D, Moreno-Bueno G, Flores JM, et al., SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells. Cancer Res 2007; 67: 11721-11731.
24. Evdokimova V, Tognon C, Ng T, et al., Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 2009; 15: 402-415.
25. Xing X, Wang SC, Xia W, et al., The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nature Med 2000; 6: 189-195. (Pubitemid 30082364)
26. Kurisetty VV, Johnston PG, Johnston N, et al., RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin. Oncogene 2008; 27: 7139-7149.
27. Yuen HF, Kwok WK, Chan KK, et al., TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction. Carcinogenesis 2008; 29: 1509-1518.
28. Kwok WK, Ling MT, Lee TW, et al., Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 2005; 65: 5153-5162. (Pubitemid 40827324)
29. RDevelopmentCoreTeam. R: A language and environment for statistical computing [Internet]. Available from: Accessed 16th December, 2010.
30. Gentleman RC, Carey VJ, Bates DM, et al., Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
31. Storey JD, Tibshirani R,. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003; 100: 9440-9445. (Pubitemid 37033947)
32. Yuen HF, Chiu YT, Chan KK, et al., Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1. Br J Cancer 2010; 102: 332-341.
33. Stauber RH, Mann W, Knauer SK,. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res 2007; 67: 5999-6002. (Pubitemid 47037475)
34. Frolova N, Edmonds MD, Bodenstine TM, et al., A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Tumour Biol 2009; 30: 148-159.
35. Kau TR, Silver PA,. Nuclear transport as a target for cell growth. Drug Discov Today 2003; 8: 78-85. (Pubitemid 36139901)
36. Sorokin AV, Kim ER, Ovchinnikov LP,. Nucleocytoplasmic transport of proteins. Biochemistry (Moscow) 2007; 72: 1439-1457.
37. Neve RM, Chin K, Fridlyand J, et al., A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006; 10: 515-527. (Pubitemid 44854747)
38. Hugo H, Ackland ML, Blick T, et al., Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213: 374-383. (Pubitemid 47509716)
39. Qin L, Liao L, Redmond A, et al., The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol Cell Biol 2008; 28: 5937-5950.
40. Baker R, Kent CV, Silbermann RA, et al., Pea3 transcription factors and wnt1-induced mouse mammary neoplasia. PLoS One 2010; 5: e8854.
41. El-Tanani M, Platt-Higgins A, Rudland PS, et al., Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J Biol Chem 2004; 279: 20794-20806. (Pubitemid 38656476)
42. Yan J, Erdem H, Li R, et al., Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res 2008; 68: 5460-5468.
43. Martinez-Estrada OM, Lettice LA, Essafi A, et al., Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nature Genet 2010; 42: 89-93.
44. Julien S, Puig I, Caretti E, et al., Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 2007; 26: 7445-7456. (Pubitemid 350158710)
45. St John MA, Dohadwala M, Luo J, et al., Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res 2009; 15: 6018-6027.
46. Hotz B, Arndt M, Dullat S, et al., Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 2007; 13: 4769-4776. (Pubitemid 47294783)